WeVote
Log In

Bill

Bill

A 4034

Places kratom on the schedules of controlled substances

2025 Regular Session Introduced by Michael Durso and 3 co-sponsors

NY A4034 would place kratom on state controlled-substances schedules, forcing licensing, penalties, and regulatory oversight for manufacturers, retailers, and users.

REFERRED TO HEALTH
0
WeVote Research Nonpartisan
Bill Summary · A 4034

Summary of Assembly Bill A 4034 – “Places kratom on the schedules of controlled substances”

Overview

A 4034 is a proposed New York Assembly bill with the stated purpose of placing kratom on the state’s schedules of controlled substances. The bill’s title indicates that kratom would be regulated under the scheduled-substances framework, placing it among substances governed by state control.

Purpose and intent

  • Primary objective: To place kratom in the state’s controlled-substances schedules.
  • By placing kratom on a scheduled list, the bill aims to subject kratom to the same regulatory and enforcement framework that governs other controlled substances in New York.

Key provisions (high level)

  • The bill would add kratom to the state’s schedules of controlled substances. Specific scheduling (e.g., which schedule), exemptions, licensing, labeling, or registration requirements, and penalties would be defined in the bill’s text.
  • Enactment would enable enforcement by state and local authorities consistent with other scheduled substances.
  • The bill would likely establish regulatory parameters, oversight by the relevant state department (commonly the Department of Health or equivalent), and potential penalties for unlawful possession, distribution, or sale.

Note: The exact details (e.g., scheduling tier, registration/licensing requirements, age restrictions, exemptions) are not provided in the summary materials you shared and would appear in the full bill text.

Who would be affected

  • Kratom manufacturers, distributors, and retailers — who would need to comply with scheduling-related regulations, licensing, and reporting.
  • Consumers and users of kratom — who could face regulated access, potential restrictions, or penalties for noncompliance.
  • Law enforcement and prosecutorial authorities — responsible for enforcement under the scheduled-substance regime.
  • The New York State Department of Health (or the relevant supervising agency) — responsible for implementing regulatory controls and public health considerations.

Procedural and timeline aspects

  • Introduced: January 30, 2025.
  • Status: Referred to the Health committee (first action recorded on January 30, 2025).
  • Related/companion legislation: S 7379 (Senate companion). The related Senate bill is listed as a companion in two entries, indicating parallel consideration in both houses.

Sponsorship

  • Primary sponsor: Edward Ra.
  • Cosponsors: Carrie Woerner, Michael Durso, Mary Beth Walsh.

Potential implications and considerations

  • Public health and safety: Scheduling could reflect concerns about misuse or health risks and facilitate regulatory controls.
  • Access and commerce: Kratom businesses would face new regulatory burdens; consumers may encounter stricter purchasing channels and age-related or other restrictions.
  • Legislative trajectory: With a Health committee referral, movement would depend on committee action, potential amendments, and subsequent floor votes. The existence of a Senate companion suggests parallel consideration across chambers.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.